S&S Investment
Overview
S&S Investment is a South Korea-based venture capital firm founded in 2018 that invests in promising companies in the bio/healthcare and ICT sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Wellmarker Bio | Aug 2021 | Series C | Co-investor |
| Pinetree Therapeutics | Oct 2025 | Series B | Co-investor |
| Illimis Therapeutics | Jul 2025 | Series B | Co-investor |
| AIMMO | Sep 2023 | VC Round | Co-investor |
| Boosters | Jan 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is S&S Investment based?
S&S Investment is headquartered in Seoul, South Korea.
When was S&S Investment founded?
S&S Investment was founded in 2018.
How many portfolio companies does S&S Investment have?
S&S Investment has 12 portfolio companies in Caplight's dataset.
What are some companies in S&S Investment's portfolio?
Portfolio companies visible on Caplight include Wellmarker Bio, Pinetree Therapeutics, Illimis Therapeutics, AIMMO, Boosters.
What was S&S Investment's most recent investment shown here?
S&S Investment's most recent investment in this portfolio sample was in Pinetree Therapeutics in 2025.
What sectors does S&S Investment focus on?
S&S Investment focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Mobility, Transportation & Logistics, Energy & Sustainability, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Mobility, Transportation & Logistics, Enterprise Software, Crypto & Web3.
What company stages does S&S Investment focus on?
S&S Investment typically invests at the Early stage.
What is S&S Investment's AUM?
S&S Investment's assets under management are estimated between $216.5M and $216.5M.